Search

Your search keyword '"Damy, T"' showing total 678 results

Search Constraints

Start Over You searched for: Author "Damy, T" Remove constraint Author: "Damy, T"
Sorry, I don't understand your search. ×
678 results on '"Damy, T"'

Search Results

1. Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009–2019)

Catalog

Books, media, physical & digital resources

9. NEWTS3EXT Newcard tele-monitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

10. Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

12. Are the PAH risk stratification tools useful in post-capillary pulmonary hypertension? Insights from the PH-HF study

13. Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: Post-hoc analysis of the APOLLO-B study

14. Evaluating the current physicians’ knowledge and patients’ pathways for diagnosing transthyretin cardiac amyloidosis (ATTR-CM) in France: An extensive survey of diverse medical specialists

15. Pulmonary hypertension due to left heart disease: First validation of the 2022 definitions in a prospective study, the PH-HF multicenter study

17. Contribution of the left atrioventricular coupling index in the prediction of atrial fibrillation in cardiac amyloidosis ATTR

18. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

19. Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

20. Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B study

26. Patient-Specific Biomechanical Modeling of Cardiac Amyloidosis – A Case Study

29. C66 PRIMARY RESULTS FROM APOLLO–B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN–MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY

32. Pulmonary hypertension in heart failure with preserved ejection fraction: Impact on mortality and hospitalization risk in PHHF registry.

33. What about markers inflammation on cardiac amyloidosis?

34. Wild-type transthyretin cardiac amyloidosis: Sex differences in prevalence, cardiac and extracardiac phenotypes, and prognosis.

35. Prognostic outcomes in heart failure based on simple severity criteria: Insights from the French national healthcare coverage database.

36. Machine learning score using multiparametric assessment for death prediction in cardiac amyloidosis.

38. Real-life evaluation of an algorithm for the diagnosis of cardiac amyloidosis

39. Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases

40. Homozygote and heterozygote transthyretin p.Val142Ile (V122I) genetic variant: Comparison of cardiac involvement, extracardiac manifestations and outcomes

41. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

44. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

45. Quels schémas vaccinaux contre les infections respiratoires chez l’insuffisant cardiaque ?

47. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

48. Clinical characteristics and outcomes of worsening heart failure patients with reduced ejection fraction: a French national healthcare database analysis

50. Impact of accelerating resting heart rate in transthyretin cardiac amyloidosis on functional and hemodynamic echocardiographic parameters.